Merck & Co.
AWARDS
NEWS
Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks. Sales of the vaccine were $539 million for the quarter, a 5% decline from the same period in 2024.
Executives don’t just get paid big bucks to operate a company. Sometimes they get paid millions to walk away.
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
Merck has not disclosed which of its peptide therapies it plans to develop oral formulations for.
Pharma stocks went on a wild ride Wednesday amid whiplashing tariff threats from the U.S. president.
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
JOBS
IN THE PRESS